SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

ProQR Announces Third Quarter 2026 Operating and Financial Results

LEIDEN, Netherlands & CAMBRIDGE, Mass., Nov. 12, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. NASDAQ:PRQR (ProQR), a clinical-stage company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today reported its fina…

PRQR

Related stories